XAF1 and glioblastoma: In this context, it will be valuable to characterize the methylation or expression status of XAF1 in recurrent tumors with TMZ-resistant phenotype to understand the molecular mechanisms of therapeutic escape and to develop more effective treatment strategies against GBM.